Instil Bio TIL
NASDAQ TIL
$6.31 -0.04 (-0.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Instil Bio (TIL) Asset Utilization Ratio (2021)

Updated

Instil Bio's (TIL) Asset Utilization Ratio came in at 0.00 for Q2 2021, down 59.0% from the prior quarter.

Analysis

Instil Bio (TIL) Asset Utilization Ratio (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Instil Bio 43.07 Mn -256.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 0.00
Mar 31, 2021 0.00
API Access

Instil Bio Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TIL&period=max&api_key=YOUR_API_KEY